Source: Annual Congress 2009 - Pulmonary circulation II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Keserü, B. Fisslthaler, N. Weissmann, I. Fleming (Frankfurt am Main, Giessen, Germany). Chronic hypoxia-induced pulmonary hypertension is linked to a decrease in the soluble epoxide hydrolase. Eur Respir J 2009; 34: Suppl. 53, 3937

Member's Comments

No comment yet.

Related content which might interest you: Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004 Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 804s Year: 2006 Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 276 Year: 2009 Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH). Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Dependence of stage of severity of chronic obstructive pulmonary disease on metalloproteinase 1, 12, surfactant protein C, microsomal epoxid hydrolase gene polymorphisms Source: Eur Respir J 2006; 28: Suppl. 50, 523s Year: 2006 Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD Source: Eur Respir J 2004; 23: 818-824 Year: 2004 Effects of the NO donor molsidomine on prostacyclin synthase gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD Source: Eur Respir J 2008; 32: 931-937 Year: 2008 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Attenuated expression and activity of dimethylarginine dimethylaminohydrolase may play a key role in monocrotaline-induced pulmonary hypertension by accumulation of endogenous NOS inhibitors in rats Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Prevention and partial reversal of monocrotaline-induced pulmonary arterial hypertension (PAH) by hsp90 inhibitors Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways Source: Eur Respir J 2013; 41: 1116-1125 Year: 2013 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Copper restriction prevents and reverses angioproliferation in experimentally induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension? Source: Eur Respir Rev 2009; 19: 68-71 Year: 2010 Right heart hypertrophy in mice deficient of the mitochondrial regulator protein p66shc is decreased after chronic hypoxic exposure by a cyclophilin D dependent mechanism Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014